The Sackler Family – A Secretive Billion Dollar Opioid Empire


Sourced from Information Clearing House

August 27, 2019

“With over 200,000 deaths caused by Opioids, it’s important to look at how this tragedy took place and who’s behind it. In this video we look at the Sackler family, the family that has caused untold damage to the lives of millions.” (ICH)

THREE ELITE MEMBERS OF THE SACKLER CLAN, 
THE  JEWISH  FAMILY  BEHIND  THE  OPIOID  CRISIS

The Darkmoon site has published several articles about the Sackler family which is directly responsible for the opioid crisis in America. This abridged version by Lasha Darkmoon of an article by Kevin MacDonald on the Occidental Observer is well worth reading. The full version by Kevin MacDonald, running to roughly 5000 words, can be read on TOOOpioids and the Crisis of the White Working Class.

The Sackler family was in the news today. They had been forced to admit culpability for the opioid crisis but, conveniently for them, had managed to “settle out of court”.  Meanwhile, the drug company Johnson & Johnson that had marketed the dangerously addictive painkillers (oxycontin)  has been fined the colossal sum of $572 million. Incidentally, not a even a hint was given in the extended BBC report on TV news that the Sackler family was Jewish. That fact had to be concealed.     

Like this? Share it now.

One thought to “The Sackler Family – A Secretive Billion Dollar Opioid Empire”

  1. here are many blames for the opioid crisis, not the least of which is the enormous profits enjoyed by the pharmaceutical salesmen, and the physicians who prescribed them. The over-the-counter status of opioids like Percocet and Xanax in Mexico, however, has accelerated the illegal trafficking by those who have access to across-the-border business in other fields of endeavor. These class-action lawsuits need be applauded – especially against Monsanto and Johnson & Johnson. It is no stretch to imagine some ambitious lawyers eventually going after the Sackler family if there’s any stretch they may be held culpable in the crisis. Beware the politicos who petition to statutorily limit the liability settlements of such entities. Let the lawyers get rich!! (If they get too greedy, they will be in danger of assassination, anyway…)


    Former Purdue Pharma head Richard Sackler defends OxyContin marketing in newly-surfaced video

    A newly obtained video deposition shows the former head of Purdue Pharma defending the marketing of its signature painkiller, OxyContin. In the video, Dr. Richard Sackler, the company’s former chairman and president, says under oath he does not know how much the family has made off the sale of OxyContin.

    CBS News has also learned Purdue Pharma has offered to settle thousands of lawsuits in connection with the nation’s opioid crisis. According to a government source with knowledge of the negotiations, the company is offering between $5 billion and $6 billion to settle.

    Sackler’s deposition was part of a 2015 lawsuit brought against Purdue Pharma by the state of Kentucky, a lawsuit that was ultimately settled for more than $20 million. The more than eight-hour video deposition was obtained by ProPublica.

    Purdue Pharma is best known as the developer of OxyContin. The company is facing billions of dollars in potential liability for its role in the nation’s opioid crisis. It’s unclear how much Purdue’s owners, the Sackler family, would have to pay.

    The company has released a statement saying it’s prepared to defend itself in court but it “has made clear that it sees little good coming from years of wasteful litigation and appeals, and the people and communities affected by the opioid crisis need help now. ”

    Talks of a potential settlement come two days after a landmark decision in Oklahoma. In that case, a judge ordered pharmaceutical giant Johnson & Johnson to pay $572 million for its role in that state’s opioid crisis.


    NEWS

    Johnson & Johnson fined $572 million for fueling opioid crisis

    Oklahoma’s attorney general accused Johnson & Johnson of a “multi-billion-dollar brainwashing campaign” to get doctors to overprescribe opioids, downplaying the addiction risks. J&J shares surged after the ruling.

        
    Logo of US pharmaceutical company Johnson & Johnson

    A judge in the US state of Oklahoma found health care giant Johnson & Johnson responsible for fueling the opioid addiction crisis in the state. The company will have to pay $572.1 million (€515 million) to Oklahoma in compensation.

    The Oklahoma case against Johnson & Johnson is one of more than 2,000 complaints that have been brought up by municipalities against drugmakers over opioid abuse nationwide.

    According to Oklahoma’s Attorney General Mike Hunter, 4,653 people were killed in opioid-related deaths from 2007 to 2017.

    Hunter said Johnson & Johnson created “the worst man-made public health crisis in the history of our country and the state,” accusing the company of carrying out a “multi-billion-dollar brainwashing campaign” to get doctors to overprescribe the drug.

    Read more: Opioids in Africa: cheap and accessible

    Funds for addiction treatment

    Oklahoma’s is the first legal case to successfully bring a pharmaceutical giant to trial for the opioid crisis and win. Prosecutors argued that the company marketed opioids aggressively for years, by overstating their effectiveness and downplaying the addiction risk.

    Judge Thad Balkman said prosecutors successfully demonstrated that the company contributed to a “public nuisance” through its deceptive advertisement of highly addictive prescription painkillers.

    “Those actions compromised the health and safety of thousands of Oklahomans,” Balkman said.

    The prosecution had sought $17 million in compensation, but Balkman said the case was not strong enough for such a figure.

    According to the ruling, the compensation money will go to funding an “abatement plan” for care for addicts, families and communities ravaged by the crisis.

    Read more: Britain’s opioid crisis takes on US dimension

    The company said it would appeal the decision, arguing that the law was being inappropriately applied and that its products had a very small role in the opioid epidemic.

    “The unprecedented award for the state’s ‘abatement plan’ has sweeping ramifications for many industries and bears no relation to the company’s medicines or conduct,” said Johnson & Johnson Executive Vice President Michael Ullmann.

    The success of the Oklahoma case could provide hope for other states. Attorneys for the plaintiffs in Ohio called the Oklahoma judgment “a milestone amid the mounting evidence against the opioid pharmaceutical industry.”

    “While public nuisance laws differ in every state, this decision is a critical step forward for the more than 2,000 cities, counties, and towns we represent in the consolidation of federal opioid cases,” they said in a statement.

    jcg/aw (dpa, Reuters, AFP, AP)

    Johnson & Johnson tried for allegedly causing an “opioid epidemic”


    Settlement talks accelerating in Purdue Pharma opioid lawsuits, plaintiffs say

    Columbus — State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation’s opioid crisis.

    Purdue has been cast by attorneys and addiction experts as a main villain in the crisis for producing a blockbuster drug while understating its addiction risk. A government source with knowledge of the negotiations said Purdue Pharma is offering between $5 billion and $6 billion.

    In a statement, the Stamford, Connecticut-based company said it’s prepared to defend itself but sees little good in years of “wasteful litigation and appeals.”

    “Purdue believes a constructive global resolution is the best path forward, and the company is actively working with the state attorneys general and other plaintiffs to achieve this outcome,” the company said.

    News of the settlement talks involving more than 2,000 lawsuits against the company and other players in the painkiller industry comes about two months before the first federal trial over the toll of opioids is scheduled to start in Cleveland.

    NBC reported that Purdue presented a plan for it to declare Chapter 11 bankruptcy and then restructure into a for-profit “public benefit trust.”

    Paul Farrell Jr., a lead plaintiffs’ lawyer representing local governments, said all sides remain under a gag order: “All we can confirm is that we are in active settlement discussions with Purdue.”

    Attorneys general representing several states also confirmed the accelerated negotiations.

    Ohio Attorney General David Yost is “actively engaged in conversations with Purdue,” said spokeswoman Bethany McCorkle, declining further comment.

    Kylie Mason, spokeswoman for Florida Attorney General Ashley Moody, declined comment on details of any possible settlement but said the state will “continue to aggressively pursue justice – to ensure those companies complicit in the opioid crisis pay for the pain and suffering inflicted on our state.”

    Purdue Pharma is owned by members of the Sackler family, who have given money to cultural institutions around the world, including the Smithsonian Institution, New York City’s Metropolitan Museum of Art and London’s Tate Modern. The New York Times reported late Tuesday the payout would include $3 billion from the Sackler family. In addition, the Sacklers would sell another drug company, Mundipharma, which would add $1.5 billion to the settlement.

    In March, Purdue and members of the Sackler family reached a $270 million settlement with Oklahoma to avoid a state trial on the toll of opioids there.

    Lawsuits filed by more than 2,000 state, local and tribal governments have cast Purdue as a chief villain in an overdose crisis that has killed more than 400,000 people in the U.S. since 2000.

    The lawsuits assert the company aggressively sold OxyContin as a drug with a low chance of triggering addictions despite knowing that wasn’t true.

    Purdue’s drugs are just a slice of the opioids prescribed, but critics assign a lot of the blame to the company because it developed both the drug and an aggressive marketing strategy.

    “Our mission here has always been clear – make Purdue Pharma and the other manufacturers and distributors pay for what they did to Pennsylvania and its people, and put the Sackler family out of the opioid business for good,” said Jacklin Rhoads, spokeswoman for Pennsylvania Attorney General Josh Shapiro, who has staffers at the Cleveland negotiations.

    On Monday, an Oklahoma judge found Johnson & Johnson guilty of fueling the state’s opioid crisis and ordered the corporation to pay $572 million in a landmark ruling. It was one of the biggest monetary awards in U.S. history.

    In making his ruling, Cleveland County District Judge Thad Balkman, in Norman, said Johnson & Johnson bears responsibility for helping to fuel Oklahoma’s opioid epidemic by aggressively marketing painkillers. Balkman took about a month to issue his judgement after a seven-week trial.

    —————————

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.